MDXH Profitability Analysis: Past Growth, Margins, Return on Capital, Free Cash Flow, and more - MDxHealth SA - Alpha Spread
M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 2.63 USD 2.33% Market Closed
Market Cap: 71.8m USD
Have any thoughts about
MDxHealth SA?
Write Note

Profitability Summary

MDxHealth SA's profitability score is 22/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

22/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

22/100
Profitability
Score
22/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Margins Comparison
MDxHealth SA Competitors

Country BE
Market Cap 71.8m USD
Net Margin
-50%
Country US
Market Cap 341.9B USD
Net Margin
10%
Country US
Market Cap 180.5B USD
Net Margin
10%
Country US
Market Cap 127.8B USD
Net Margin
32%
Country US
Market Cap 123.3B USD
Net Margin
-5%
Country US
Market Cap 104.5B USD
Net Margin
4%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 142.3B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.5B USD
Net Margin
-557%
Country US
Market Cap 35.4B USD
Net Margin
-3%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
MDxHealth SA Competitors

Country Company Market Cap ROE ROA
BE
MDxHealth SA
NASDAQ:MDXH
71.8m USD
-664%
-43%
US
Abbvie Inc
NYSE:ABBV
341.9B USD
54%
4%
US
Amgen Inc
NASDAQ:AMGN
180.5B USD
49%
3%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
127.8B USD
17%
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.3B USD
-3%
-2%
US
Gilead Sciences Inc
NASDAQ:GILD
104.5B USD
5%
2%
US
Epizyme Inc
F:EPE
94.1B EUR
-877%
-67%
AU
CSL Ltd
ASX:CSL
142.3B AUD
16%
7%
US
Seagen Inc
F:SGT
39.3B EUR
-28%
-21%
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD
-588%
-178%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.4B USD
35%
-2%
Country BE
Market Cap 71.8m USD
ROE
-664%
ROA
-43%
Country US
Market Cap 341.9B USD
ROE
54%
ROA
4%
Country US
Market Cap 180.5B USD
ROE
49%
ROA
3%
Country US
Market Cap 127.8B USD
ROE
17%
ROA
13%
Country US
Market Cap 123.3B USD
ROE
-3%
ROA
-2%
Country US
Market Cap 104.5B USD
ROE
5%
ROA
2%
Country US
Market Cap 94.1B EUR
ROE
-877%
ROA
-67%
Country AU
Market Cap 142.3B AUD
ROE
16%
ROA
7%
Country US
Market Cap 39.3B EUR
ROE
-28%
ROA
-21%
Country US
Market Cap 38.5B USD
ROE
-588%
ROA
-178%
Country US
Market Cap 35.4B USD
ROE
35%
ROA
-2%

See Also

Discover More
Back to Top